MichaelEdwardMontejoMD

PubMed

• 20 citations
  High-dose intensity-modulated chemoradiotherapy in vulvar squamous cell carcinoma: Outcome and toxicity.
  Anupam Rishi, Madeline Rollins, Kamran Ahmed, Dylan C. Hunt, Papri Sarkar
  Gynecologic Oncology. 2020-02-01
• Calibrating tumor growth and invasion parameters with spectral spatial analysis of cancer biopsy tissues.
  Stefano Pasetto, Michael Montejo, Mohammad U Zahid, Marilin Rosa, Robert Gatenby
  NPJ Systems Biology and Applications. 2024-10-02
• 78 citations
  Reproducibility of F18-FDG PET radiomic features for different cervical tumor segmentation methods, gray-level discretization, and reconstruction algorithms.
  B.A. Altazi, Geoffrey Zhang, Daniel C. Fernandez, Michael E. Montejo, Dylan C. Hunt
  Journal of Applied Clinical Medical Physics. 2017-09-11

Journal Articles

• Radiotherapy for early stage diffuse large B-cell lymphoma with or without double or triple hit genetic alterations  
  Grass GD, Mills MN, Ahmed KA, Liveringhouse CL, Montejo MJ, Robinson TJ, Chavez JC, Harrison LB, Kim S, Leuk Lymphoma, 1/1/2018
• IMRT with Simultaneous Integrated Boost and Concurrent Chemotherapy for Locoregionally Advanced Head and Neck Squamous Cell Carcinoma  
  Montejo, ME, Shrieve, DC, Bentz, BG, Hunt, JP, Buchmann, LO, Agarwal, N, and Hitchcock, YJ, Int J Radiat Oncol Biol Phys, 1/1/2011
• Treatment of Intermediate Risk Prostate Cancer with I-125 Permanent Interstitial Brachytherapy Monotherapy A Review of the H Lee Moffitt Cancer Center Experience  
  Torres-Roca, JF, Cantor, AB, Shukla, S, Montejo, ME, Friedland, J, Seigne, JD, Heysek, R, Me Marco, ML, Kelley, S, and Pow-Sang, J, Urologic Oncology, 1/1/2006

Abstracts/Posters

• Clinical Outcome and Late Toxicity following Definitive Intensity Modulated Radiotherapy for Squamous Cell Carcinoma of the Vulva
  Anupam Rishi, Madeline Rollins, Daniel Fernandez, Kamran Ahmed, Mitchel Hoffman, Mian Shahzad, Sachin Apte, Jing-Yi Chern, Hye Chon, Robert Wenham, Michael Montejo, ASTRO, 1/1/2018
• IMRT with Simultaneous Integrated Boost (IMRT-SIB) with Concurrent Cisplatin for Advanced Squamous Cell Carcinoma of the Head and Neck
  Montejo, ME, Shrieve, DC, Bentz, BG, Hunt, JP, Buchmann, LO, Agarwal, N, and Hitchcock, YJ, American Society of Therapeutic Radiation Oncology (ASTRO), 1/1/2009
• Treatment of Intermediate Risk Prostate Cancer with I-125 Permanent Interstitial Brachytherapy Monotherapy. A Review of the H Lee Moffitt Cancer Center Experience
  Torres-Roca, JF, Cantor, AB, Shukla, S, Montejo, ME, Friedland, J, Seigne, JD, Heysek, R, Me Marco, ML, Kelley, S, and Pow-Sang, J, ASTRO, Int J Radiat Oncol Biol Phys, 1/1/2004